Dec. 15, 2011 – A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer’s disease, based on the findings of a study by scientists at the Salk Institute for Biological Studies published in PLoS ONE.
See the rest here:
... continue reading
A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer’s disease, based on the findings of a new study.
Follow this link:
Alzheimer’s drug candidate may be first ... continue reading
Salk scientists develop new drug that improves memory and prevents brain damage in mice A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer’s disease, based on the findings of a study published Dec. 14 in PLoS ONE. When given to mice with ... continue reading
Citeline, an Informa business unit, and the world’s leading research authority on pharmaceutical clinical trials recently reviewed the findings from the 14th International Conference on Alzheimer’s Disease (ICAD 2011/AAIC 2011) July 16-21, 2011, noting that while pharma continues to develop beta amyloid targeting drugs, amyloid targets are moving ahead in ... continue reading
VANCOUVER, British Columbia, Feb. 10 (UPI) — Canadian researchers say their findings challenge the idea marijuana tempers Alzheimer’s disease.
See the original post here:
Marijuana doesn’t help Alzheimer’s disease (UPI)